Selenium and Cardiovascular Diseases - An Update

Biomedical and Environmental Sciences

Volumn 10, Issue 2-3, 1997, Pages 220-226

  Huttunen, Jussi K ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

SELENIUM;

ANIMAL; CARDIOVASCULAR DISEASE; EPIDEMIOLOGY; HUMAN; NUTRITIONAL DEFICIENCY; REVIEW;

ANIMALS; CARDIOVASCULAR DISEASES; CONFOUNDING FACTORS (EPIDEMIOLOGY); DEFICIENCY DISEASES; HUMANS; SELENIUM;

EID: 0031227866     PISSN: 08953988     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Alfthan, G., Aro, A., Arvilommi, H., and Huttunen, J. K. (1991). Selenium metabolism and platelet glutathione peroxidase activity in healthy Finnish men: Effects of selenium yeast, selenite, and selenate. Am. J. Clin. Nutr. 53, 120-125.
2. Aro, A., Alfthan, G., Soimakallio, S., and Voutilainen, E. (1986). Se concentrations in serum and angiographically defined coronary artery disease are uncorrelated. Clin. Chem. 32, 911-912.
3. Beaglehole, R., Jackson, R., Watkinson, J., Scragg, R., Lay, Yee R. (1990). Decreased blood selenium and risk of myocardial infarction. Int. J. Epid. 19, 918-922.
4. Beard, T., Carrié, D., Boyer, M. J., Boudjemaa, B., Ferrieres, J., Delay, M., and Bernadet P. (1994). Production de radicaux libres oxygénés au cours de l'infarctus du myocarde traité par thrombolyse. Arch. Mal. Caeur. 87, 1289-1296.
5. Beck, M. A., Kolbeck, P. C., Shi, Q., Rohr, L. H., Morris, V. C., and Levander, O. A. (1994). Increased virulence of a human enterovirus (Coxsackievirus B3) in selenium deficient mice. J. Infect. Dis. 170, 351-357.
6. Beck, M. A., Shi, Q., Morris, V. C., and Levander, Q. A. (1995). Rapid genomic evolution of a non-virulent Coxsackievirus B3 in selenium-deficient mice results in selection of identical virulent isolates. Nature Med. 1, 433-436.
7. Bukkens, S. G., de Vos, N., Kok, F. J., Schouten, E. G., deBruijn, A. M., and Hofman, A. (1990). Selenium status and cardiovascular risk factors in healthy Dutch subjects. Am. Coll. Nutr. 9, 128-135.
8. Burk, R. F. (1978). Selenium in nutrition. World Rev. Nutr. Diet. 30, 88-106.
9. Combs, G. F. Jr. and Combs, S. B. (1984). The nutritional biochemistry of selenium. Ann. Rev. Nutr. 4, 257-280.
10. Hampel, G., Watanabe, K., Weksler, B. B., and Jaff, E. A. (1989). Selenium deficiency inhibits prostacyclin release and enhances production of platelet activating factor by human endothelial cells. Biochim. Biophys. Acta 1006, 151-158.
11. Jossa, F., Trevisan, M., Krogh, V., Farinaro, E., Giumetti, D., Fusco, G., Galasso, R., Panico, S., Frascatore, S., Mellone, C., and Mancini, M. (1991). Serum selenium and coronary heart disease risk factors in southern Italian mean. Atherosclerosis 87, 129-134.
12. Kardinaal, A. F. M., Kok, F. J., Kohlmeier, L., Martin-Moreno, J. M., Ringstad, J., Gómez-Aracena, J., Mazaev, V. P., Thamm, M., Martin, B. C., Aro, A., Kark, J. D., Delgado-Rodriguez, M., Riemersma, R. A., van't Veer, P., and Huttunen, J. K. (1997). Association between toenail selenium and risk of acute myocardial infarction in Europe: the EURAMIC study. Am. J. Epid. 145, 373-379.
13. Kok, F. J., Hofman, A., Witteman, J. C. M., deBruijn, A. M., Kruyssen, D. H. C. M., deBruin, M., and Valkenburg, H. A. (1989). Decreased selenium levels in acute myocardial infarction. JAMA 261, 1161-1164.
14. Kok, F. J., deBruijn, A. M., Vermeeren, R., Hofman, A., van Laar, A., deBruin, M., Hermus, R. J., and Valkenburg, H. A. (1987). Serum selenium, vitamin antioxidants, and cardiovascular mortality: a 9-year follow-up study in the Netherlands. Am. J. Clin. Nutr. 45, 462-468.
15. Kok, F. J., van Poppel, G., Melse, J., Verheul, E., Schouten, E. G., Kruyssen, D. H., and Hofman, A. (1991). Do antioxidants and polyunsaturated fatty acids have a combined association with coronary atherosclerosis? Atherosclerosis 86, 85-90.
16. Lafont, A., Marwick, T. H., Chisolm, G. M., van Lente, F., Vaska, K. J., and Whitlow, P. L. (1996). Decreased free radical scavengers with reperfusion after coronary angioplasty in patients with acute myocardial infarction. Am. Heart J. 131, 219-223.
17. Lloyd, B., Lloyd, R. S., and Clayton, B. E. (1983). Effect of smoking, alcohol, and other factors on the selenium status of a healthy population. J. Epid. Comm. Health 37, 213-217.
18. Meydani, M. (1992). Modulation of the platelet thromboxane A2 and aortic prostacyclin synthesis by dietary selenium and vitamin E. Biol. Trace Elem. Res. 33, 79-86.
19. Miettinen, T. A., Alfthan, G., Huttunen, J. K., Pikkarainen, J., Naukkarinen, V., Mattila, S., and Kumlin, T. (1983). Serum selenium concentration related to myocardial infarction and fatty acid content of serum lipids. Br. Med. J. 287, 517-519.
20. Moore, J. A., Noiva, R., and Wells, I. C. (1984). Selenium concentrations in plasma of patients with arteriographically defined coronary atherosclerosis. Clin. Chem. 30, 1171-1173.
21. Niskanen, J., Marniemi, J., Piironen, O., Maatela, J., Mäki, J., Vuori, I., Seppänen, A., Kallio, V., and Aromaa, A. (1986). Trace element levels in serum and urine of subjects died of coronary heart disease. Acta Pharmacol. Toxicol. (Copenh) 59, 340-343.
22. Oliver, M. F. (1995). Antioxidant nutrients, atherosclerosis, and coronary heart disease. Br. Heart J. 73, 299-301.
23. Oster, O., Dahm, M., and Oelert, H., (1993). Element concentrations (selenium, copper, zinc, iron, magnesium, potassium, phosphorus) in heart tissues of patients with coronary heart disease correlated with physiological parameters of heart. Eur. Heart J. 14, 770-774.
24. Oster, O. and Prellwitz, W. (1990). Selenium and cardiovascular disease. Biol. Trace Elem. Res. 24, 91-103.
25. Pucheu, S., Coudray, C., Vanzetto, G., Favier, A., Machecourt, J., and DeLeiris, J. (1995). Time-course of changes in plasma levels of trace elements after thrombolysis during the acute phase of myocardial infarction in humans. Biol. Trace Elem. Res. 47, 171-182.
26. Ringstad, J., Jacobsen, B. K., Thomassen, Y., and Thelle, D. S. (1987). The Tromsø Heart Study: Serum selenium and risk of myocardial infarction - a nested case-control study. J. Epid. Comm. Health 41, 329-332.
27. Salonen, J. T., Alfthan, G., Huttunen, J. K., Pikkarainen, J., and Puska, P. (1982). Association between cardiovascular death and myocardial infarction and serum selenium in a matched-pair longitudinal study. Lancet 2, 175-179.
28. Salonen, J. T., Salonen, R., Penttilä, I., Herranen, J., Jauhiainen, M., Kantola, M., Lappeteläinen, R., Mäenpää, P. H., Alfthan, G., and Puska, P. (1985). Serum fatty acids, apolipoproteins, selenium and vitamin antioxidants and the risk of death from coronary artery disease. Am. J. Cardiol. 56, 226-231.
29. Salonen, J. T., Salonen, R., Seppänen, K., Kantola, M., Parviainen, M., Alfthan, G., Mäenpää, P. H., Taskinen, E., and Rauramaa, R. (1988). Relationship of serum selenium and antioxidants to plasma lipoproteins, platelet aggregability and prevalent ischaemic heart disease in eastern Finnish men. Atherosclerosis 70, 155-160.
30. Salonen, J. T., Salonen, R., Seppänen, K., Kantola, M., Suntioinen, S., and Korpela, H. (1991). Interactions of serum copper, selenium, and low density lipoprotein cholesterol in atherogenesis. Br. Med. J. 302, 756-760.
31. Schamberger, R. J., Willis, C. C., and McCormack, L. J. (1979). Selenium and heart disease. III. Blood selenium and heart mortality in 19 states. In Trace Substances in Environmental Health-XIII (Hemphill, D. D. Ed.), pp. 59-63. University of Missouri Press, Columbia.
32. Simonetta, S., Hennekens, C. H., Morris, J. S., Willett, W. C., and Stampfer, M. J. (1995). Plasma levels of the antioxidant selenium and risk of myocardial infarction among U.S. physicians. Am. J. Cardiol. 76, 1218-1221.
33. Suadicani, P., Hein, H. O., and Gyntelberg, F. (1992). Serum selenium concentration and risk of ischaemic heart disease in a prospective cohort study of 3000 males. Atherosclerosis 96, 33-42.
34. Swanson, C. A., Longnecker, M. P., Veillon, C., Howe, M., Levander, O. A., Taylor, P. R., McAdam, P. A., Brown, C. C., Stampfer, M. J., and Willett, W. C. (1990). Selenium intake, age, gender, and smoking in relation to indices of selenium status of adults residing in a seleniferous area. Am. J. Clin. Nutr. 52, 858-862.
35. Varo, P., Alfthan, G., Huttunen, J. K., and Aro, A. (1994). Nationwide selenium supplementation in Finland-effects on diet, blood and tissue levels, and health. In Selenium in Biology and Human Health (R. F. Burk, Ed.), pp. 199-218. Springer-Verlag, New York.
36. Virtamo, J. and Huttunen JK. (1988). Minerals, trace elements and cardiovascular disease. Ann. Clin. Res. 20, 102-113.
37. Virtamo, J., Valkeila, E., Alfthan, G., Punsar, S., Huttunen, J. K., and Karvonen, M. J. (1985). Serum selenium and the risk of coronary heart disease and stroke. Am. J. Epidemiol. 122, 276-282.
38. Witztum, J. L. and Steinberg, D. (1991). Role of oxidized low density lipoprotein in atherogenesis. J. Clin. Invest. 88, 1785-1792.
39. Yang, G. Q. (1985). Keshan disease: An endemic selenium-related deficiency disease. In Trace Elements in Nutrition of Children (R. K. Chandara, Ed.), 273-290. Raven Press, New York.